Percentage of Her2 positive cells in immunohistochemistry-equivocal (2+) invasive breast cancer and its significance as a predictive value for the amplification status

被引：0
|
作者：
Marras, V. [1 ]
Satta, G. [1 ]
Fedeli, M. A. [1 ]
Trombetta, M. [1 ]
Lako, K. [1 ]
Meloni, M. [1 ]
Fara, A. M. [1 ]
Camboni, A. C. [1 ]
Doneddu, V. [1 ]
Manca, A. [1 ]
Tanda, F. [1 ]
机构：
[1] AOU Sassari, UO Anat Patol, Sassari, Italy
来源：
VIRCHOWS ARCHIV | 2017年 / 471卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-01-034
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [21] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    MODERN PATHOLOGY, 2019, 32
  • [22] HER2 Immunohistochemistry Positivity is Strongly Predictive of HER2 Positive Breast Cancer Response to Neoadjuvant Therapy
    Zhao, Jing
    Zhang, Chao
    Suo, Aili
    Shi, Qiuying
    Wei, Zhimin
    Li, Zaibo
    Krishnamurti, Uma
    Li, Xiaoxian
    LABORATORY INVESTIGATION, 2019, 99
  • [23] Resolving the ERBB2 (HER2) Status of Invasive Breast Cancers with Double-Equivocal HER2 Status by Immunohistochemistry and Fluorescence In-situ Hybridization
    Hon, Jane Date
    Zhang, Xinmin
    Edmonston, Tina Bocker
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2016, 146 : S96 - S96
  • [24] The frequency of HER2 amplification and the percentage of membrane staining in HER2 2+invasive carcinomas of the breast
    Lee, Andrew H. S.
    Ellis, Ian O.
    VIRCHOWS ARCHIV, 2022, 481 (02) : 327 - 327
  • [25] Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
    Yuefeng Wang
    Julia Y. S. Tsang
    Yongmei Cui
    Ji Cui
    Ying Lin
    Songli Zhao
    Patrick T. W. Law
    Sai Yin Cheung
    Enders K. O. Ng
    Gary M. K. Tse
    Zunfu Ke
    Scientific Reports, 7
  • [26] The predictive value of HER2 in breast cancer
    Piccart, M
    Lohrisch, C
    Di Leo, A
    Larsimont, D
    ONCOLOGY, 2001, 61 : 73 - 82
  • [27] Correlation of HER2 gene and chromosome 17 status with pathologic factors in her2 2+ invasive breast cancer
    MacGrogan, G.
    Chibon, F.
    de Mascarel, I.
    Sierankowski, G.
    Brouste, V.
    MODERN PATHOLOGY, 2007, 20 : 40A - 40A
  • [28] Robust and accurate digital measurement for HER2 amplification in HER2 equivocal breast cancer diagnosis
    Wang, Yuefeng
    Tsang, Julia Y. S.
    Cui, Yongmei
    Cui, Ji
    Lin, Ying
    Zhao, Songli
    Law, Patrick T. W.
    Cheung, Sai Yin
    Ng, Enders K. O.
    Tse, Gary M. K.
    Ke, Zunfu
    SCIENTIFIC REPORTS, 2017, 7
  • [29] Correlation of HER2 gene and chromosome 17 status with pathologic factors in her2 2+ invasive breast cancer
    MacGrogan, G.
    Chibon, F.
    de Mascarel, I.
    Sierankowski, G.
    Brouste, V.
    LABORATORY INVESTIGATION, 2007, 87 : 40A - 40A
  • [30] Change of Her2/neu protein expression level and Her2/neu status in local metastases of breast cancer with its equivocal (2+) expression in primary tumour
    Konyshev, K.
    Kazantseva, N.
    Sazonov, S.
    VIRCHOWS ARCHIV, 2017, 471 : S295 - S296
12345